Category Science & Technology
Discovery may help researchers design vaccines that exploit the notorious mutability of HIV by training the immune system to attack the virus where it's most vulnerable.
The use of a synthetic drug derived from the saliva of vampire bats appears to extend the time window for treatment of acute ischemic strokes from the current three to nine hours after symptoms first appear, according to the results of a new international study.
The National Science Foundation has awarded $10 million to a team of researchers headed by geneticist John Doebley to study the molecular and functional diversity of the maize (corn) genome.
Probing the last genomic frontier of higher organisms, an international team of scientists has succeeded in sequencing a little understood - but critical - genetic domain in rice.
The identification and characterization of the novel "CBR703" class of inhibitors through combined efforts in biochemistry, genetics and structural modeling with contributions from UW–Madison scientists and biopharmaceutical company Cumbre Inc. are described in a paper published in the Oct. 24 issue of Science.
It is the equivalent of the courageous soldier throwing himself on a grenade, says Jon S. Thorson, a professor of pharmacy and the senior author of a paper describing a newly-discovered method of antibiotic resistance published in the Sept. 12 edition of the journal Science.
UW-Madison is part of a collaboration of 11 Midwestern institutions selected as one of the new Centers of Excellence for Biodefense and Emerging Infectious Diseases Research.
More than 35 organizations from 12 Midwestern states are gathering in Chicago on Wednesday, Sept. 10, for a summit meeting to showcase Midwestern biotechnology research and entrepreneurial opportunities for Japanese biotech leaders.
Models show that genes from crops rapidly can take over those in related wild plants.
Wisconsin Gov. Jim Doyle pledged his support March 5 to helping Wisconsin's biotechnology industry and to blunting legislative attacks on stem cell science.
Relieving the growing congestion on interstate highways and city streets will require more than simply building additional roads. Engineering is part of the solution, but economic, political, social and environmental considerations also determine what can and should be done. That's the concept behind a new interdisciplinary graduate-level certificate program offered by the Nelson Institute for Environmental Studies at UW–Madison.
The governor has signed a budget repair bill addressing Wisconsin's $1 billion budget deficit with measures including some cuts to UW System funding.
To prepare professionals for the burgeoning field of biotechnology, the university will offer a new part-time graduate degree program beginning fall 2002.
As science begins to accumulate and explore plant and animal genomes - the entire set of genetic instructions for a particular organism - a new revolution in agriculture is in the offing and, according to university biologist Robert Goodman, promises a long-lasting and favorable impact on agriculture worldwide.
In a promising new research effort, a mathematical program is helping automate and fine-tune the arduous process of radiation surgery.
The newly completed genomic sequence of E. coli O157:H7 reveals how these potentially deadly bacteria are armed with a surprisingly wide range of genes that may trigger illness.
The battle over bad bugs in the food supply is intensifying at UW–Madison, with a new faculty hiring effort focused on the growing worldwide concern about food-borne pathogens.
Probing the microscopic life found in the submerged recesses of an abandoned Wisconsin lead and zinc mine, scientists have found compelling evidence that microorganisms play a key role in the formation of mineral deposits. The finding could help jump-start new remediation efforts for contaminated mining sites.
From a routine study of the life span of human skin cells, a university research project gave rise to an astonishing accident: A line of skin cells that simply wouldn't die.
A new process transforms the lowly cardiovirus into a potential multipurpose vaccine that eventually may be used trigger an immune response to a host of human and animal afflictions from malaria to HIV.